Featured Question

What would you recommend regarding selection and sequencing of the immune checkpoint therapies and other current therapies, including chemotherapies, in bladder cancer? When is the use of monotherapy versus combination therapy warranted?

See The Answer

Get the latest
science delivered
to your inbox

Answers in CME updates are
available in YOUR specialty.

Sign-up Now!

Featured Activities


Immune Checkpoint Blockade Therapy in Bladder Cancer: Expert Perspectives on Appropriate Patient Selection and Nuances of Clinical Use

Course Director
Elizabeth R. Plimack, MD, MS
Fox Chase Cancer Center,
Temple Health
Philadelphia, Pennsylvania


Challenging Cases in Multiple Sclerosis

Course Director
Aaron E. Miller, MD
Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Mount Sinai School of Medicine
New York, New York